Why Does an Angiomyolipoma Aneurysm Increase Bleeding Risk?

An intralesional aneurysm—a bulging, weakened segment of a blood vessel inside the tumor—increases the risk of bleeding because it represents a direct structural weak point that is prone to rupture ^[1]. While renal angiomyolipoma (AML) is a benign (non-cancerous) kidney tumor, its abnormal blood vessels can burst and cause severe internal bleeding ^[1]. Doctors historically focused on the overall size of the tumor to estimate bleeding risk, but research shows that the presence and size of an aneurysm is often a more direct warning sign ^[2].

What Is an Intralesional Aneurysm or Pseudoaneurysm?

Angiomyolipomas are made up of three components: blood vessels (angio), muscle (myo), and fat (lipoma). The blood vessels inside an AML are abnormally formed; they are often twisted and lack the normal elastic tissue that makes healthy blood vessels flexible and strong ^[1].

Because of this abnormal structure, the pressure of blood flowing through the tumor can damage the vessels in two ways:

• True Aneurysm: The wall of the blood vessel stretches and balloons outward.
• Pseudoaneurysm: The vessel wall is injured, causing a contained leak of blood just outside the vessel ^[1].

If the pressure becomes too great for these fragile spots, they can burst. This can cause Wunderlich syndrome, which is spontaneous, non-traumatic bleeding into the kidney and the surrounding retroperitoneal space ^[1].

How Are They Found?

Aneurysms inside an AML are identified using imaging tests that map blood flow:

• Contrast-Enhanced CT or CTA (CT Angiography): By injecting a contrast dye into your bloodstream, doctors can take detailed pictures of the tumor’s blood supply. An aneurysm may appear as a bright, contrast-filled outpouching in the weakened vessel ^{[3] [4]}.
• Digital Subtraction Angiography (DSA): This is an invasive, catheter-based procedure threaded into the kidney’s arteries. It provides a highly detailed map of the tumor’s blood vessels and is usually reserved for planning or performing treatment ^{[5] [6]}.

Why 5 Millimeters Is Often a Discussion Point

You might hear your doctor mention that an aneurysm is 5 millimeters (mm) or larger. While there is no universal rule that mandates immediate surgery, doctors often use a 5-mm aneurysm diameter as a point to discuss preventative treatment ^{[7] [8]}.

Here is how doctors interpret the 5-mm threshold:

• It can be a stronger risk marker than tumor size: Historically, doctors used a total tumor size of 4 centimeters (cm) to decide when to treat. However, observational studies suggest that an aneurysm measuring larger than 5 mm may be a better predictor of a future rupture than the 4-cm tumor rule ^[2].
• It is associated with bleeding: Research comparing ruptured and unruptured AMLs has found that aneurysms are significantly more common in the tumors that have bled ^[9].
• It is not a guarantee: A 5-mm aneurysm is a risk-stratification tool, not an absolute predictor. Some smaller aneurysms can still rupture, and many larger ones never do ^{[4] [2]}.

The Role of Tumor Vascularity

Beyond the size of a specific aneurysm, the overall vascularity (blood supply) of the tumor adds important context. Tumors with a very rich network of feeding arteries or a high “angiomyogenic” component (mostly blood vessels and muscle, rather than fat) are generally associated with a higher risk of bleeding ^{[10] [11]}.

If imaging shows prominent, twisted feeding vessels or multiple aneurysms, specialists may interpret this as a sign of high vascular fragility ^{[3] [12]}. These findings are always considered alongside your symptoms, tumor size, and whether the AML is growing.

Treatment vs. Surveillance Trade-offs

Finding an aneurysm in your AML will prompt a discussion about the safest path forward ^[13]:

• Active Surveillance: If the aneurysm is small and you have no symptoms, your doctor may recommend regular imaging to monitor it ^[14]. This is a clinician-defined schedule, not simply “waiting.” Most asymptomatic AMLs grow very slowly, and surveillance is strongly supported by research ^{[14] [15]}.
• Selective Arterial Embolization (SAE): This minimally invasive procedure blocks the specific artery feeding the aneurysm ^[16]. While SAE shrinks the tumor and reduces bleeding risk, it can cause short-term pain or fever (post-embolization syndrome), and the tumor may eventually regrow, requiring repeat treatment ^[17].
• Kidney-Sparing Surgery (Partial Nephrectomy): Surgery removes the tumor while leaving the healthy part of the kidney intact. It has a lower risk of the tumor returning compared to SAE, but carries standard operative risks, including bleeding and loss of some kidney tissue ^{[16] [18]}.

Your care team will also consider factors like pregnancy plans. The hormonal and circulatory changes of pregnancy may promote AML growth or bleeding, making preconception discussions with your urologist or interventional radiologist highly advisable ^{[8] [19]}.

When to Seek Emergency Care

Because a ruptured aneurysm can cause life-threatening internal bleeding, it is critical to know the warning signs. Do not wait for your next scan if you experience sudden symptoms.

Seek emergency medical help immediately if you experience:

• Sudden, severe flank, abdominal, or back pain
• Fainting, near-fainting, or marked dizziness
• Sudden weakness, confusion, or pale, clammy skin
• A rapid heartbeat

Note: A retroperitoneal bleed can occur without any visible blood in your urine. Ensure emergency providers know you have an angiomyolipoma with an aneurysm so they can image your kidneys quickly.